Risk Management continues to be an area of increased focus for ensuring patient safety. In the last year, biopharma has witnessed notable changes to this function of drug safety– both in a more complete understanding of best practices, as well as increased regulatory requirements. This all results in ongoing scrutiny on Risk Management and Risk minimisation. In the new risk management landscape, managing commitments proactively will become increasingly vital.

Axian Consulting and Orbit by Feith have partnered to help companies meet the challenges in Risk Management. Together, we prepare organisations to optimally manage commitment tracking. In our May 25th webinar, we will show how we help organisations map, and optimise their process, and involve the correct people to ensure tracking delivers expected improvements, collects the right data, and reports appropriate information within companies and to inspectors.